This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema.
Expert opinion on investigational drugs, 29(6), 547-554
Citation
Shaw, Lincoln T; Mackin, Anna; Shah, Reanna; Jain, Siona; Jain, Prisha; Nayak, Ravi; Hariprasad, Seenu M. (2020). Risuteganib-a novel integrin inhibitor for the treatment of non-exudative (dry) age-related macular degeneration and diabetic macular edema.. Expert opinion on investigational drugs, 29(6), 547-554. https://doi.org/10.1080/13543784.2020.1763953